Drug Eruption and Interactions - PHARMACEUTICAL REVIEW

34 AMPICILLIN
(1995): Romano A+, Allergy 50, 113
(1994): Grayson ML+, Clin Infect Dis 18, 683
(1994): Shelley WB+, Cutis 53, 40 (observation)
(1993): Romano A+, J Invest Allergol Clin Immunol 3, 53
(1993): Warrington RJ+, J Allergy Clin Immunol 92, 626
(1988): Hou SR, Chung Hua Nei Ko Tsa Chih (Chinese) 27, 36
(1987): Pavithran K, Indian J Lepr 59, 309
(1986): Cabo HA+, Med Cutan Ibero Lat Am (Spanish) 14, 177
(1986): de Haan P+, Allergy 41, 75
(1986): Sonntag MR+, Schweiz Med Wochenschr (German)
116, 142 (8%)
(1985): Bruynzeel DP+, Dermatologica 171, 429
(1985): Hefelfinger DC, Ala Med 55, 16
(1983): Bianchi C+, Med Cutan Ibero Lat Am (Spanish) 11, 113
(1983): Scioli C+, Boll Ist Sieroter Milan (Italian) 62, 287
(1982): Dourmischev AL+, Dermatol Monatsschr (German)
168, 469
(1982): Gatter KC+, Clin Allergy 12, 279
(1981): Jick H+, J Clin Pharmacol 21, 456 (5.9%)
(1981): Lin CS+, Arch Dermatol 117, 282
(1980): Kraemer MJ+, Pediatrics in Review 1, 197
(1980): Porter D+, Lancet 1, 1037
(1980): Scherzer W+, Derm Beruf Umwelt (German) 28, 175
Exfoliative dermatitis
(1985): Fong PH+, Ann Acad Med Singapore 14, 693
Fixed eruption
(2000): Brabek E+, Dtsch Med Wochenschr 125(42), 1260
(1998): Mahboob A+, Int J Dermatol 37, 833
(1990): Bharija SC+, Dermatologica 181, 237
(1990): Gaffoor PMA+, Cutis 45, 242
(1987): Sharma SN, J Assoc Physicians India 35, 608
(1986): Kanwar AJ+, Dermatologica 172, 315
(1986): Panagariya A, J Ass Physicians India 34, 458
(1984): Chan H-L, Arch Dermatol 120, 542
(1983): Chan H-L, Int J Dermatol 23, 607
Linear IgA dermatosis
(2004): Shimanovich I+, JAmAcadDermatol51(1), 95
(2002): Cohen LM+, JAmAcadDermatol46, S32 (passim)
(1996): Tranvan A+, JAmAcadDermatol35, 865
(1981): Boffety B+, Journées Dermatologiques de Paris
(French), 53–53a
Pemphigus
(1997): Brenner S+, JAmAcadDermatol36, 919
(1996): Takizawa H+, Am J Gastroenterol 91, 1654
(1993): Brenner S+, Isr J Med Sci 29, 44
(1986): Brenner S+, JAmAcadDermatol14, 453
(1986): Wilson JP+, Drug Intell Clin Pharm 20, 219
(1980): Fellner MJ+, Int J Dermatol 19, 392
Photo-recall
(2002): Blanco J+, J Investig Allergol Clin Immunol 12(3), 215
Pityriasis rosea
(1987): Olumide Y, Int J Dermatol 26, 234
Pruritus (1–5%)
(2006): Blumenthal HL, Beachwood, OH (personal
communication) (observation)
(2003): Gei AF+, Obstet Gynecol 102(6), 1332
(1996): Adcock BB+, Arch Fam Med 5, 301
(1982): Bernhard JD+, Cutis 29, 158
(1980): Kraemer MJ+, Pediatrics in Review 1, 197
Psoriasis
(1993): Litt JZ, Beachwood, OH (personal case) (observation)
(1992): Breathnach SM+, Adverse Drug Reactions and the Skin
Blackwell, Oxford, 141 (passim)
(1990): Saito S+, JDermatol17, 677
(1988): Tsankov N+, JAmAcadDermatol19, 629
(1987): Katz M+, JAmAcadDermatol17, 918
(1986): Verner E+, Harefuah (Hebrew) 110, 132
Purpura
(1993): Pang BK+, Ann Acad Med Singapore 22, 870
(1990): Hannedouche T+, J Antimicrob Chemother 20, 3
(1982): Beeching NL+, J Antimicrob Chemother 10, 479
(1981): Valman HB, Br Med J Clin Res Ed 283, 970
Pustules
(1995): Lim JT+, Cutis 56, 163
(1994): Jay S+, Arch Dermatol 130, 787 (localized)
(1991): Roujeau J-C+, Arch Dermatol 127, 1333
(1990): Guy C+, Nouv Dermatol (French) 9, 540
Rash (sic) (1–10%)
Stevens–Johnson syndrome
(1990): Cavanzo FJ+, Gastroenterology 99, 854
(1990): Chan HL+, Arch Dermatol 126, 43
(1987): Howell CG+, JPediatrSurg22, 994
(1985): Ting HC+, Int J Dermatol 24, 587
(1985): Turck M, Hosp Pract Off Ed 20, 49
Toxic epidermal necrolysis (10%)
Phlebitis
Pseudoporphyria
(2004): Phung TL+, JAmAcadDermatol51(2), S80 (with
cefepime)
Serum sickness
Thrombophlebitis